0001437749-19-018139.txt : 20190910 0001437749-19-018139.hdr.sgml : 20190910 20190910142334 ACCESSION NUMBER: 0001437749-19-018139 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20190910 DATE AS OF CHANGE: 20190910 EFFECTIVENESS DATE: 20190910 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Little Pharma, Inc. CENTRAL INDEX KEY: 0001752787 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-321225 FILM NUMBER: 191084936 BUSINESS ADDRESS: STREET 1: 170 AMSTERDAM AVENUE STREET 2: #6C CITY: NEW YORK STATE: NY ZIP: 10023 BUSINESS PHONE: 856-816-6660 MAIL ADDRESS: STREET 1: 170 AMSTERDAM AVENUE STREET 2: #6C CITY: NEW YORK STATE: NY ZIP: 10023 D/A 1 primary_doc.xml X0708 D/A LIVE 0001752787 Little Pharma, Inc. 170 Amsterdam Avenue #6C New York NY NEW YORK 10023 856-816-6660 DELAWARE None None Corporation true 2018 Ethan Lauf Goldstein 170 Amsterdam Avenue #6C New York NY NEW YORK 10023 Executive Officer Director Promoter Pharmaceuticals Decline to Disclose 06b true 0001209191-18-050747 2018-08-31 true true true The Convertible Notes are outstanding but the underlying offering is complete. false 0 707500 707500 0 false 21 0 0 0 false Little Pharma, Inc. /s/ Ethan Lauf Goldstein Ethan Lauf Goldstein President and Chief Executive Officer 2019-09-09